Zelmic will participate at CPHI Frankfurt on November 1-3, 2022 David Sagna is excited to meet new clients and suppliers to discuss topical drug development and the opportunities with the new IMP topical manufacturing unit. This trip was facilitated in connection with the EU.
Read moreJoin us at NLSdays for CMC discussions.
Read moreMeet us in Copenhagen 6th of September
http://www.formulationsbioavailability.com/
Read morePh.D. Anna Runnsjö will be present at the upcoming Skin Forum 2022 in Malmö, Sweden.
Read morePharma Outscouring 2021
Read moreZelmic will attend The Future of Swedish and Danish Life Science on the 2nd of September. David Sagna, CEO, and Ph.D. Susanne Nilsson, Head of Development will be present at the event.
Read moreDavid Sagna, CEO and Ph. D Susanne Nilsson, Head of Development, will be present during the event this year.
Read moreMEET US AT 2nd Annual Dermatology Drug Development Summit 2021, 17-19 February, Virtual Event | 9AM – 5PM CET.
Read moreWe are fortunate to be able to remain open and to assist and support our clients’ needs during the fight against COVID-19.
Read moreWe are now GMP certified by the Swedish Medical Products Agency! We are happy to announce a successfully implementation of a new QMS system at Zelmic…
Read more